Is Medtronic plc (MDT) a Buy, Sell, or Hold?
Medtronic plc
NYSE:MDT
$79.3 USD
-$4.27 (-5.11%)
- Volume
- 8.5M
- Average Volume
- 10.33M
- Market Capitalization
- $101.51B
- P/E Ratio
- 21.15
- Dividend Yield
- 3.59%
- Price Target
- $91.00
- Year High
- $106.33
- Year Low
- $73.31
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.76
- Current Ratio
- $2.13
Industry, Sector & symbol
| Stock Exchange | NYSE |
| CEO | Geoffrey Straub Martha |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Current Symbol | MDT |
| CUSIP | G5960L103 |
| CIK | 0001613103 |
| Web | https://www.medtronic.com |
| Phone | 353 1 438 1700 |
| Currency | USD |
| Employees | 95000 |
| Country | IE |
Liquidity
| Debt-to-Equity Ratio | 0.57 |
| Payout Ratio | 0.76 |
| Current Ratio | 2.13 |
| Quick Ratio | 1.62 |
| Cash Ratio | 0.17 |
Sales & Book Value
| Annual Sales | $36.36B |
| Price / Sales | 2.79 |
| Cash Flow | 4.23 |
| Price / Cash Flow | 18.71 |
| Price / Book | 2.06 |
Price Target and Rating
| Average Stock Price Forecast | $91.00 |
| High Stock Price Forecast | $119.00 |
| Low Stock Price Forecast | $80.00 |
| Forecast Upside/Downside | -12.86% |
| Consensus Rating | Neutral |
| Rating Score(0-5) | 3 |
| Research Coverage | 51 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $3.73 |
| Trailing P/E Ratio | 21.15 |
| PEG Ratio | 6.40 |
| P/E Growth | 6.40 |
| Net Income | $4.8B |
| Net Margin | 13.20% |
| Pretax Margin | 16.87% |
| Return on Equity | 9.85% |
| Return on Assets | 5.16% |
Financials Score
| AltmanZ Score | 2.79 |
| Piotroski Score | 8.00 |
| Working Capital | 13.13B |
| Total Assets | 93.03B |
| Ebit | 6.85B |
| Market Cap | 106.97B |
| Total Liabilities | 42.96B |
Poll Results
About Medtronic plc (NYSE:MDT) Stock
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventi ... ons (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
Medtronic (MDT) Exceeds Market Returns: Some Facts to Consider
2026-07-10 18:51:12
Medtronic (MDT) reached $83.87 at the closing of the latest trading day, reflecting a +1.8% change compared to its last close.
Medtronic: Undervalued, And The Tailwinds Are Just Getting Started
2026-07-10 11:16:35
I initiate coverage on Medtronic, highlighting its status as a leading medtech name with premium margins. MDT offers an attractive diversification opportunity, combining consistent performance with accelerated revenue growth. The stock trades at undervalued levels, supporting a long-term bullish thesis and a defensive investment approach.
Medtronic: Guidance Built To Be Beaten - Buy
2026-07-10 06:32:24
Medtronic plc is rated buy with a $92 price target, reflecting conservative fiscal 2027 guidance and resilient growth platforms. Fiscal 2026 delivered $36.4B in revenue, the strongest growth in a decade, led by Cardiovascular and ablation solutions outpacing market rates. Guidance for fiscal 2027 excludes potential catalysts—MiniMed separation, tariff refunds, and Blackstone payment relief—implying room for upside surprises.
Medtronic: A Near Decade High Dividend For This Aristocrat
2026-07-09 08:32:23
Medtronic is a dividend aristocrat with a near-decade high yield, making it an attractive long-term income opportunity. The company is experiencing strong revenue growth, driven by its leading positions in cardiovascular and neuroscience medical devices. While current free cash flow payout ratios are sustainable, investors should monitor future dividend growth rates closely.
3 High-Yield Dividend Stocks to Buy and Hold Forever (Hint: AbbVie Makes the List)
2026-07-07 10:45:00
AbbVie is hitting its stride now that it has transitioned past Humira's patent expiration. Medtronic is a steady dividend payer with some intriguing upside in robotics-assisted surgery.
Why Is Medtronic (MDT) Up 1.5% Since Last Earnings Report?
2026-07-03 12:31:08
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
Medtronic (MDT) Stock Sinks As Market Gains: What You Should Know
2026-06-30 18:51:09
Medtronic (MDT) reached $78.23 at the closing of the latest trading day, reflecting a -3.34% change compared to its last close.
Is Medtronic PLC (MDT) a Bargain After 3.3% Drop? GF Value Says Undervalued
2026-06-30 17:12:00
On June 30, 2026, Medtronic PLC (MDT) shares fell 3.3% today, bringing the current price to $78.23. The stock has traded between $73.31 and $106.33 over the pas
Frequently Asked Questions
-
What is the current Medtronic plc (MDT) stock price?
-
Medtronic plc(NYSE:MDT) stock price is $79.3 in the last trading session. During the trading session, MDT stock reached the peak price of $106.33 while $73.31 was the lowest point it dropped to. The percentage change in MDT stock occurred in the recent session was --5.11% while the dollar amount for the price change in MDT stock was -$-4.27.
-
MDT's industry and sector of operation?
-
The NYSE listed MDT is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of MDT?
-
Laura Mauri | Senior Vice President and Chief Scientific & Medical Officer
Alex Gu | Senior VP & President of Greater China Region
Brett A. Wall | Executive Officer
Michelle Quinn | Executive Vice President, General Counsel & Secretary
Mark Ploof | Senior Vice President of Global Operations and Business Services -
How many employees does MDT have?
-
Number of MDT employees currently stands at 95000. MDT operates from Building Two, Parkmore Business Park West, Galway, None H91 4K49, IE.
-
Link for MDT official website?
-
Official Website of MDT is: https://www.medtronic.com
-
How do I contact MDT?
-
MDT could be contacted at phone #353 1 438 1700 and can also be accessed through its website. MDT operates from Building Two, Parkmore Business Park West, Galway, None H91 4K49, IE.
-
How many shares of MDT are traded daily?
-
The average number of MDT shares traded daily for last 3 months was 10.33M.
-
What is the market cap of MDT currently?
-
The market value of MDT currently stands at $101.51B with its latest stock price at $79.3